APA (7th ed.) Citation

RM, E., MA, E., SM, F., SZ, E., NME, A., MM, S., & AM, F. (2026). Repurposing felodipine via hyaluronic acid-coated cetylosomes (HCCs) for parenteral active targeting of cancer: Box-Behnken statistical optimization, in vitro characterization, and in vivo studies. Drug delivery and translational research. https://doi.org/10.1007/s13346-026-02090-0

Chicago Style (17th ed.) Citation

RM, El-Dahmy, Eltabeeb MA, Fayez SM, El-Emam SZ, Adl NME, Saber MM, and Fahmy AM. "Repurposing Felodipine via Hyaluronic Acid-coated Cetylosomes (HCCs) for Parenteral Active Targeting of Cancer: Box-Behnken Statistical Optimization, in Vitro Characterization, and in Vivo Studies." Drug Delivery and Translational Research 2026. https://doi.org/10.1007/s13346-026-02090-0.

MLA (9th ed.) Citation

RM, El-Dahmy, et al. "Repurposing Felodipine via Hyaluronic Acid-coated Cetylosomes (HCCs) for Parenteral Active Targeting of Cancer: Box-Behnken Statistical Optimization, in Vitro Characterization, and in Vivo Studies." Drug Delivery and Translational Research, 2026, https://doi.org/10.1007/s13346-026-02090-0.